Stephen A. Hurly

2016

In 2016, Stephen A. Hurly earned a total compensation of $874.6K as President and Chief Executive Officer at Eleven Biotherapeutics.

Compensation breakdown

Option Awards$755,511
Salary$119,093
Total$874,604

Hurly received $755.5K in option awards, accounting for 86% of the total pay in 2016.

Hurly also received $119.1K in salary.

Rankings

In 2016, Stephen A. Hurly's compensation ranked 8,873rd out of 14,075 executives tracked by ExecPay. In other words, Hurly earned more than 37.0% of executives.

ClassificationRankingPercentile
All
8,873
out of 14,075
37th
Division
Manufacturing
3,436
out of 5,489
37th
Major group
Chemicals And Allied Products
1,164
out of 1,895
39th
Industry group
Drugs
917
out of 1,538
40th
Industry
Pharmaceutical Preparations
731
out of 1,176
38th
Source: SEC filing on April 7, 2017.

Hurly's colleagues

We found four more compensation records of executives who worked with Stephen A. Hurly at Eleven Biotherapeutics in 2016.

2016

Abbie Celniker

Eleven Biotherapeutics

Chief Executive Officer

2016

John McCabe

Eleven Biotherapeutics

Chief Financial Officer

2016

Karen Tubridy

Eleven Biotherapeutics

Former Chief Development Office

2016

Arthur DeCillis

Eleven Biotherapeutics

Chief Medical Officer

News

In-depth

You may also like